Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib
Year: 2025
Type: article
Language: en
Topic: Lung Cancer Treatments and Mutations
Authors and affiliations:
raw_author_name: Pascale Tomasini
raw_affiliation_strings: Aix Marseille University Hospital Nord, Multidisciplinary Oncology and Therapeutic Innovations Department, Marseille, France. Electronic address: pascale.tomasini@ap-hm.fr
raw_author_name: Oscar Juan-Vidal
raw_affiliation_strings: Department of Medical Oncology, University Hospital La Fe, Valencia, Spain
raw_author_name: Raffaele Califano
raw_affiliation_strings: The Christie NHS Foundation Trust and Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom
raw_author_name: Chien-Chung Lin
raw_affiliation_strings: National Cheng Kung University Hospital, Tainan, Taiwan
raw_author_name: Pauline Hulo
raw_affiliation_strings: Thoracic Oncology Unit, Nantes University Hospital, Nantes, France
raw_author_name: Christophe Dooms
raw_affiliation_strings: UZ Leuven, Leuven, Belgium
raw_author_name: Jian Fang
raw_affiliation_strings: Beijing Cancer Hospital, Beijing, China
raw_author_name: Ana Blasco
raw_affiliation_strings: Hospital General Universitario de Valencia, Valencia, Spain
raw_author_name: Dariusz Kowalski
raw_affiliation_strings: Department of Lung Cancer and Chest Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
raw_author_name: Jorge Salinas
raw_affiliation_strings: CEMAIC Private Medical Center, Córdoba, Argentina
raw_author_name: Govind Babu
raw_affiliation_strings: Health Care Global Enterprises pvt Ltd Bangalore, India
raw_author_name: Tho Lye Mun
raw_affiliation_strings: Beacon Hospital Sdn. Bhd., Petaling Jaya, Malaysia
raw_author_name: Alessandra Bearz
raw_affiliation_strings: Centro di Riferimento Oncologico -IRCCS, Aviano, Italy
raw_author_name: Veerle Surmont
raw_affiliation_strings: UZ Gent, Gent, Belgium
raw_author_name: Clarissa Baldotto
raw_affiliation_strings: Instituto D'Or de Pesquisa e Ensino (IDOR), Rio de Janeiro, Brazil
raw_author_name: Richu Sharma
raw_affiliation_strings: Artemis Hospital, Gurugram Haryana, India
raw_author_name: Oscar Arrieta
raw_affiliation_strings: Medica Sur, Mexico City, Mexico
raw_author_name: Katarzyna Stencel
raw_affiliation_strings: Polish Mother's Memorial Hospital - Research Institute, Łódź, Poland; Wielkopolska Center of Pulmonology and Thoracic Surgery of Eugenia and Janusz Zeyland, Poznan, Poland
raw_author_name: Cynthia Card
raw_affiliation_strings: Arnie Charbonneau Cancer Institute Calgary, Alberta, Canada
raw_author_name: Alona Zer
raw_affiliation_strings: Rambam Health Care Corporation Campus, Tel-Aviv, Israel
raw_author_name: Erminia Massarelli
raw_affiliation_strings: City of Hope Comprehensive Cancer Center, Duarte, CA
raw_author_name: Bruno Fang
raw_affiliation_strings: Astera Cancer Care, East Brunswick, NJ
raw_author_name: Sandeep Mashru
raw_affiliation_strings: Kaiser Permanente Northwest, Portland, OR
raw_author_name: Julia Schuchard
raw_affiliation_strings: Johnson & Johnson, Horsham, PA
raw_author_name: Jan Sermon
raw_affiliation_strings: Johnson & Johnson, Beerse, Belgium
raw_author_name: Joris Diels
raw_affiliation_strings: Johnson & Johnson, Beerse, Belgium
raw_author_name: Pei-Ling Chu
raw_affiliation_strings: Johnson & Johnson, Raritan, NJ
raw_author_name: Monica Withelder
raw_affiliation_strings: Johnson & Johnson, Malvern, PA
raw_author_name: Joshua M. Bauml
raw_affiliation_strings: Johnson & Johnson, Spring House, PA
raw_author_name: Sujay Shah
raw_affiliation_strings: Johnson & Johnson, Raritan, NJ
raw_author_name: Mahadi Baig
raw_affiliation_strings: Johnson & Johnson, Horsham, PA
raw_author_name: Enriqueta Felip
raw_affiliation_strings: Vall d'Hebron University Hospital Vall d'Hebron Institute of Oncology, Barcelona, Spain